Skip to main content

Table 6 Six-month stability study of the optimized formulation

From: Formulation development, optimization and characterization of mucoadhesive minitablets of cefuroxime axetil: in vitro, ex vivo and in vivo pharmacokinetic evaluation

Time (Months)

Drug content (%)*

Mucoadhesive strength (g)*

0

99.4 ± 1.256

19.741 ± 0.51

3

99.25 ± 1.568

19.25 ± 0.53

6

99.14 ± 1.058

18.89 ± 0. 47

  1. *Mean ± SD, n = 6